arrow
J

Jinli Luo

china traditional chinese medicine holdings co limited
H指数:25
被引数:2,702

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial

结构性炎症和上皮间质转化决定了对nivolumab的敏感性: 一项安慰剂对照的随机III期试验

2025-07-210
OA
A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma
2024-08-210
OAAI
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment (vol 12, 1751, 2021)
2021-06-073
OAAI
Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment
2021-03-1974
OAAI